Can a 10-week online program help people with depression and schizophrenia get out more?

NCT ID NCT06336616

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a behavioral program called SWITCH that teaches people with serious mental illness (like depression, schizophrenia, or bipolar disorder) to set goals, use rewards, and build habits to do more activities outside the home. 52 participants will attend weekly online sessions for 10 weeks, then monthly sessions for 3 months. Researchers will track their activity, mood, and GPS location to see if the program helps them participate more in their community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Behavioral activation program (SWITCH)

What this could lead to

If it works, this could point toward a simple, non-drug way to help people with serious mental illness feel more engaged and active in their communities.

What could go wrong

This is a small, early study with no control group, so results may not be generalizable. The intervention requires internet access and willingness to carry a GPS phone, which may limit who can participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder major depressive disorder Psychotic Disorders schizoaffective disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Temple University

    Philadelphia, Pennsylvania, 19120, United States